News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
Daraprim Discounts Offered
Karen Zusi | Nov 26, 2015
Turing Pharmaceuticals will soon offer discounts to hospitals for its toxoplasmosis-fighting drug, the company announced, but some say the proposed price reductions are not enough.
Pfizer and Allergan to Merge
Bob Grant | Nov 23, 2015
The two drugmakers will join forces in a $160 billion deal—if it’s given the regulatory green light.
Tracy Vence | Oct 22, 2015
A specialty pharmaceuticals company announces plans to produce a toxoplasmosis drug containing the same active ingredient as the pill at the center of an ongoing drug-pricing controversy.
Teva Buys Mexican Pharma Firm
Bob Grant | Oct 5, 2015
The Israeli drugmaker is purchasing the pharmaceutical company Rimsa for $2.3 billion.
Biotech Stocks Take a Hit
Kerry Grens | Sep 30, 2015
Some say the biotech bubble has burst over concerns that drug prices are too high—and may soon be regulated.
Drug Pricing Incites Outrage
Kerry Grens | Sep 22, 2015
Will public disgust over dramatic hikes in the cost of medications change industry practices?
TS Live: Pharma Feast
Kerry Grens | Aug 26, 2015
A sampling of the biggest acquisitions reshaping the life sciences industry in 2015
Novartis Buys Rights to GSK MS Drug for $1 Billion
Kerry Grens | Aug 24, 2015
The multiple sclerosis treatment has yet to be tested in Phase 3 clinical trials.
Valeant Scoops Sprout for $1 Billion
Tracy Vence | Aug 24, 2015
The Canadian pharmaceutical firm is buying the American drugmaker behind the newly approved “female Viagra.”
Doctor Who Blocked Thalidomide Dies
Kerry Grens | Aug 11, 2015
Frances Oldham Kelsey, a physician who halted use of a drug that caused birth defects in babies, has passed away at age 101.